
Long-acting reversible contraception (compared to short-acting reversible contraception)
HealthcareLiterature review updated September 2018.
Long-acting reversible contraception (LARC) includes contraceptives such as subdermal implants and intrauterine devices. This analysis compares LARC to short-acting reversible contraceptives (SARC), such as oral or injectable contraceptives. The included study took place in three North Carolina health centers and provided 24 months of LARC or SARC to adult women seeking contraceptives.
ALL |
META-ANALYSIS |
CITATIONS |
|
| Meta-Analysis of Program Effects | ||||||||||||
| Outcomes measured | No. of effect sizes | Treatment N | Effect sizes (ES) and standard errors (SE) | Unadjusted effect size (random effects model) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ES | SE | Age | ES | p-value | ||||||||
Engagement/Retention Retention and engagement in treatment or care. |
1 | 177 | 0.970 | 0.269 | 24 | 0.970 | 0.001 | |||||
Unintended pregnancy Pregnancy that is not planned for (i.e., is unwanted or mistimed). |
1 | 177 | -0.200 | 0.274 | 24 | -0.200 | 0.465 | |||||
Citations Used in the Meta-Analysis
Hubacher, D., Spector, H., Monteith, C., & Chen, P.L. (2018). Not seeking yet trying long-acting reversible contraception: A 24-month randomized trial on continuation, unintended pregnancy and satisfaction. Contraception, 97,(6), 524-532.